Overexpression of NRF2 leads to reduced MMP-13 and MMP-9 levels, which has been linked not only to amelioration of inflammation in arthritis and ocular models but also to decreased cancer cell invasiveness via the Nrf2/HO-1 axis [145]. Here, NFE2L2 is linked to cancer.